Evidence map›Paper›PMID 31994902›Full record

ArticleJournal of cutaneous medicine and surgery

Canadian Burden of Skin Disease From 1990 to 2017: Results From the Global Burden of Disease 2017 Study.

Alanna C Bridgman, Christina Fitzmaurice, Robert P Dellavalle, Chante Karimkhani Aksut, Ayman Grada, Mohsen Naghavi, Navid Manafi, Andrew T Olagunju, Tinuke O Olagunju, Ranjani Somayaji and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cutaneous medicine and surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alanna C Bridgman4257 School of Medicine, Queen's University, Kingston, ON, Canada.ORCID 0000-0002-5274-1527
Christina Fitzmaurice7284 Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.ORCID 0000-0002-6802-3394
Robert P Dellavalle12226 School of Medicine, University of Colorado Denver, Aurora, CO, USA.
Chante Karimkhani AksutDermatology Service, US Department of Veterans Affairs (VA), Denver, CO, USA.
Ayman Grada12259 School of Medicine, Boston University, Boston, MA, USA.ORCID 0000-0002-5321-0584
Mohsen Naghavi7284 Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Navid Manafi440827 Ophthalmology Department, Iran University of Medical Sciences, Tehran, Iran.
Andrew T Olagunju62703 Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
Tinuke O Olagunju62703 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Ranjani Somayaji2129 Department of Medicine, University of Calgary, Calgary, AB, Canada.
Aaron M DruckerDivision of Dermatology, University of Toronto, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSkin diseases can have high morbidity that can be costly to society and individuals. To date, there has been no comprehensive assessment of the burden of skin disease in Canada.

objectivesTo evaluate the burden of 18 skin and subcutaneous diseases from 1990 to 2017 in Canada using the Global Burden of Disease (GBD) data.

methodsThe 2017 GBD study measures health loss from 359 diseases and injuries in 195 countries; we evaluated trends in population health in Canada from 1990 to 2017 using incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs). Data are presented as rates (per 100 000), counts, or percent change with the uncertainty interval in brackets.

resultsFrom 1990 to 2017 for all skin diseases, DALY rates increased by 8% to 971 per 100 000 (674-1319), YLD rates increased by 8% to 897 per 100 000 (616-1235), YLL rates increased by 4% to 74 per 100 000 (53-89), and death rates increased by 18% to 5 per 100 000 (3-6). DALY rates for melanoma increased by 2% to 54 per 100 000 (39-68), for keratinocyte carcinoma by 14% to 17 per 100 000 (16-19), and for skin and subcutaneous disease by 8% to 900 per 100 000 (619-1233). The observed over expected ratios were higher for skin and subcutaneous disease (1.37) and keratinocyte carcinoma (1.17) and were lower for melanoma (0.73).

conclusionsThe burden of skin disease has increased in Canada since 1990. These results can be used to guide health policy regarding skin disease in Canada.

Indexed as

AdultAgedCanadaFemaleGlobal Burden of DiseaseHumansMaleMiddle AgedSkin Diseasesdisabilityincidenceprevalenceskin disease

Identifiers

PMID31994902
PMCPMC7109598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.